Patients Health literacy for the intellectually disabled: is pharma d... What is health literacy and why is it important?
Patients Leveraging real-world data to meet payers’ needs Payers are becoming savvier in accepting real-world data.
Patients Time for change: PhRMA survey shows insurance creates barrie... Health insurance is not enough to provide the necessary affordable access to care for the US’ most vulnerable, finds new PhRMA report.
Patients Time for a new model in patient access Mig Sleeper, vice president, Global Pricing for Astellas Pharma Europe, explains why we must rethink how value is defined as we enter a new technological era for medicines.
Patients Time to take patient engagement to the next level Patient engagement in pharma is evolving, with some companies doing it better than others.
Patients UK-wide whole genome sequencing for newborns is feasible - b... Genomics England, the Department of Health and Social Care’s genome-sequencing hub, has this year ann
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
